https://ourglp1.com/news/glp1-macular-degeneration-amd-observational-studyOurGLP1en2026-08-06T08:15:00+01:00Could GLP-1 medicines lower macular-degeneration risk? What the evidence shows https://ourglp1.com/news/oral-glp1-pills-retatrutide-cagrisema-survodutide-zenagamtideOurGLP1en2026-08-05T09:15:00+01:00GLP-1 pills are here—but the ‘more powerful’ pipeline is not a settled race